VGT vs XBI
Vanguard Information Technology ETF vs SPDR S&P Biotech ETF
- • VGT has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • VGT pays a higher dividend yield (0.37%).
Side-by-side metrics
| Metric | VGT | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.37% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $146.53B | $8.30B |
YTD return | 16.40% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.29 | 1.09 |
P/E ratio | 39.12 | — |
Last price | $109.50 | $133.66 |
Inception | — | — |
Issuer | Vanguard | State Street |
VGT top holdings
| NVDA | NVIDIA Corp | 18.52% |
| AAPL | Apple Inc | 15.85% |
| MSFT | Microsoft Corp | 10.20% |
| AVGO | Broadcom Inc | 4.38% |
| MU | Micron Technology Inc | 2.02% |
| AMD | Advanced Micro Devices Inc | 1.75% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 1.74% |
| CSCO | Cisco Systems Inc | 1.65% |
| AMAT | Applied Materials Inc | 1.47% |
| LRCX | Lam Research Corp | 1.45% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About VGT
VGT (Vanguard Information Technology ETF) is US technology sector stocks. Managed by Vanguard, the fund carries $146.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 0.37%. Its largest holding is NVIDIA Corp (NVDA), which represents 18.5% of the portfolio. Basic Materials is the fund's largest sector exposure at 0.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.